PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Review Article

Volume 8 Issue 3

Novel Nutritional Formulations for Post-Stroke Rehabilitation: Scientific Potential and Clinical Applications

Christina Rahm*

September 02, 2026

View PDF

Abstract

Stroke is a major cause of mortality and long-term disability in most countries of the world, with about 795,000 Americans developing stroke every year. The conventional post-stroke rehabilitation has been based on the use of pharmaceuticals and physical therapy. However, major gaps still exist to maximize the outcomes of neurological recovery and functional outcomes. This white paper will discuss a new patent-pending treatment protocol that utilizes three proprietary nutritional formulations that are being used under a structured dosing schedule to treat post-stroke rehabilitation. The strategy combines zeolite extracts, amino acids, polyphenolic compounds, and the use of different bioactive components, which may stimulate neural repair, lower inflammation, and functional restoration. This paper assesses the scientific rationale of every element of the formulation, the possible action mechanisms, and the prospects of making contributions to the development of stroke rehabilitation research and clinical practice.

References

  1. Allen CL and Bayraktutan U. “Oxidative stress and its role in the pathogenesis of ischaemic stroke”. International Journal of Stroke 4.6 (2009): 461-470.
  2. Dirnagl U, Iadecola C and Moskowitz MA. “Pathobiology of ischaemic stroke: An integrated view”. Trends in Neurosciences 22.9 (1999): 391-397.
  3. Donnan GA., et al. “Stroke”. The Lancet 371.9624 (2008): 1612-1623.
  4. Fernstrom JD and Fernstrom MH. “Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain”. The Journal of Nutrition 137.6 (2007): 1539S-1547S.
  5. Garcion E., et al. “New clues about vitamin D functions in the nervous system”. Trends in Endocrinology & Metabolism 13.3 (2002): 100-105.
  6. Iadecola C and Anrather J. “The immunology of stroke: From mechanisms to translation”. Nature Medicine 17.7 (2011): 796-808.
  7. Katzenschlager R., et al. “Mucuna pruriens in Parkinson's disease: A double blind clinical and pharmacological study”. Journal of Neurology, Neurosurgery & Psychiatry 75.12 (2004): 1672-1677.
  8. Lamprecht M., et al. “Effects of zeolite supplementation on parameters of intestinal barrier integrity, inflammation, redox biology, and performance in aerobically trained subjects”. Journal of the International Society of Sports Nutrition 12.1 (2015): 40.
  9. Liu Z., et al. “Curcumin protects against ischemic stroke by titrating microglia/macrophage polarization”. Frontiers in Aging Neuroscience 9 (2017): 233.
  10. Mastinu A., et al. “Zeolite clinoptilolite: Therapeutic virtues of an ancient mineral”. Molecules 24.8 (2019): 1517.
  11. May JM. “Vitamin C transport and its role in the central nervous system”. In: Watson RR (Ed.), Subcellular Biochemistry, Vol. 56 (2012): 85-103.
  12. Murphy TH and Corbett D. “Plasticity during stroke recovery: From synapse to behaviour”. Nature Reviews Neuroscience 10.12 (2009): 861-872.
  13. Nobre AC, Rao A and Owen GN. “L-theanine, a natural constituent in tea, and its effect on mental state”. Asia Pacific Journal of Clinical Nutrition 17.S1 (2008): 167-168.
  14. Rohdewald P. “A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with diverse clinical pharmacology”. International Journal of Clinical Pharmacology and Therapeutics 40.4 (2002): 158-168.
  15. Sinha K, Chaudhary G and Gupta YK. “Protective effect of resveratrol against oxidative stress in the middle cerebral artery occlusion model of stroke in rats”. Life Sciences 71.6 (2002): 655-665.
  16. Tellone E., et al. “Resveratrol: A focus on several neurodegenerative diseases”. Oxidative Medicine and Cellular Longevity 2015 (2015): Article 392169.
  17. Winstein CJ., et al. “Guidelines for adult stroke rehabilitation and recovery: A guideline for healthcare professionals from the American Heart Association/American Stroke Association”. Stroke 47.6 (2016): e98-e169.
  18. Wu J., et al. “Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway”. PLoS ONE 8.3 (2013): Article e59843.
  19. Zhao J., et al. “Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats”. Neurochemical Research 35.3 (2010): 374-379.